GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Accounts Payables (2015 - 2026)

GridAI Technologies' (GRDX) quarterly Accounts Payables came in at $2.3 million in Q2 2026, down 30.46% on a YoY basis from $3.3 million in Q2 2025, and down 32.17% quarter-over-quarter from $3.4 million in Q4 2025.

Analysis

GridAI Technologies (GRDX) Accounts Payables (2015 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Accounts Payables for 12 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accounts Payables fell 30.46% year-over-year to $2.3 million; the trailing twelve-month figure through Jun 2026 stood at $2.3 million (down 30.46% YoY), and the FY2025 full-year result was $3.4 million, up 14.27% from the prior year.
  • Accounts Payables eased to $2.3 million in Q2 2026 per GRDX's latest filing, from $3.4 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $5.0 million in Q3 2025 and bottomed at $469760.0 in Q1 2023.
  • Historically, Accounts Payables has averaged $2.4 million across 5 years, with a median of $2.3 million in 2026.
  • The sharpest annual moves came in 2023 and 2024: Accounts Payables plunged 86.38% in 2023, then jumped 433.89% in 2024.
  • Over 5 years, Accounts Payables stood at $720040.0 in 2022, then declined by 23.02% to $554277.0 in 2023, then surged by 433.89% to $3.0 million in 2024, then rose by 14.27% to $3.4 million in 2025, then tumbled by 32.17% to $2.3 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $2.3 million, $3.4 million, and $5.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.52 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 25.08 Mn
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00 2.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.29 Mn
Dec 31, 2025 3.38 Mn
Sep 30, 2025 4.97 Mn
Jun 30, 2025 3.30 Mn
Mar 31, 2025 2.85 Mn
Dec 31, 2024 2.96 Mn
Sep 30, 2024 2.21 Mn
Jun 30, 2024 2.01 Mn
Mar 31, 2024 2.00 Mn
Dec 31, 2023 554,277.00
Sep 30, 2023 579,291.00
Jun 30, 2023 1.59 Mn
Mar 31, 2023 469,760.00
Dec 31, 2022 720,040.00
Sep 30, 2022 3.58 Mn
Jun 30, 2022 3.97 Mn
Mar 31, 2022 3.45 Mn
Dec 31, 2021 2.71 Mn
Sep 30, 2021 18.58 Mn
Jun 30, 2021 4.64 Mn